BULIS VERONICA SANCHEZ (VP, Corporate Controller) sold 2.5% of their position (239.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $3.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2025ACC: 0002095702-25-000003
Officer· VP, Corporate Controller
Since Feb 2026
-239.00
Net shares
Net seller
$3.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
239.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−239.00
Price / share
$16.10
Trade value
$3.85K
% of position
2.5%
11/10/2025
9.45K→9.21K
Total
Net shares
−239.00
Net value
-$3.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2025 | S · Sale | −239.00 | $16.10 | $3.85K | 2.5% | 9.45K | 9.21K |
| Total | −239.00 | -$3.85K | ||||||
Derivative Transactions0
No derivative transactions reported